...
机译:CardioniaBetes:心血管临床医生的核心竞争力在2型糖尿病管理中的快速发展时代
Division of Cardiology University of British Columbia;
Division of Endocrinology and Metabolism University of Toronto;
Division of Cardiology Li Ka Shing Knowledge Institute and Keenan Centre for Biomedical Science;
Division of Cardiology Li Ka Shing Knowledge Institute and Keenan Centre for Biomedical Science;
Endocrinology and Metabolism North York General Hospital and LMC Diabetes and Endocrinology;
Division of Cardiology Li Ka Shing Knowledge Institute and Keenan Centre for Biomedical Science;
Division of Endocrinology and Metabolism Li Ka Shing Knowledge Institute and Keenan Centre for;
Population Health Research Institute and Department of Medicine McMaster University;
Division of Endocrinology University of British Columbia;
Heart and Lung Institute Laval University;
Department of Cardiac Sciences Libin Cardiovascular Institute of Alberta Cumming School of;
Division of Endocrinology University of British Columbia;
Division of Surgery Li Ka Shing Knowledge Institute and Keenan Centre for Biomedical Science;
Section of Endocrinology and Metabolism John Buhler Research Centre University of Manitoba;
Division of Endocrinology McGill University Health Centre McGill University;
机译:CardioniaBetes:心血管临床医生的核心竞争力在2型糖尿病管理中的快速发展时代
机译:3.5-O7的能力和信任在澳大利亚南亚南亚和澳大利亚的2型糖尿病和心血管疾病管理中的临床医生和患者的相互作用
机译:临床更新:糖尿病动脉粥样硬化性心血管疾病和2型糖尿病的心力衰竭-作用机理,治疗和临床考虑
机译:使用多专家多标准决策,确定2型糖尿病患者心血管并发症的显着危险因素及高血压
机译:减少糖尿病的混乱:集中的教育和管理风险降低策略旨在降低2型糖尿病患者的心血管风险。
机译:1型糖尿病遗传风险评分可以识别快速发展为胰岛素治疗的GAD65自身抗体阳性2型糖尿病患者
机译:3.5-O7竞争力和信任临床医生与2型糖尿病和心血管疾病管理之间的相互作用,南亚南亚和澳大利亚盎格鲁澳大利亚人
机译:工业糖尿病指南 - 评估新型抗糖尿病治疗2型糖尿病的心血管风险